Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiency

QJM: An International Journal of Medicine

Volumn 89, Issue 8, 1996, Pages 599-611

  Mazodier, P ^a   Elzouki, A N Y ^b,c   Segelmark, M ^c   Eriksson, S ^b  

^a Section North   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; AZATHIOPRINE; CYCLOPHOSPHAMIDE; SALAZOSULFAPYRIDINE; STEROID; TRYPSIN; TRYPSIN INHIBITOR;

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANEURYSM; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BIOPSY; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; EMPHYSEMA; FATALITY; FEMALE; FIBROSIS; FOLLOW UP; HEMODIALYSIS; HUMAN; JOINT; KIDNEY; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER DISEASE; MALE; NECROTIZING ARTERITIS; PHENOTYPE; PRIORITY JOURNAL; PURPURA; SKIN; SWEDEN; SYSTEMIC VASCULITIS; TREATMENT OUTCOME; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS;

EID: 0029781329     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.8.599     Document Type: Article

References (60)

1. Crystal RG. α1-antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy. J Clin Invest 1990; 83:1343-52.
2. Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1988; 84(suppl 6A): 13-31.
3. Van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and markers of disease activity in Wegener's granulomatosis. Lancet 1985; i:425-9.
4. Savage COS, Winearls CG, Jones S, Marshall P, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987; i:1389-93.
5. Abbott F, Jones S, Lockwood CM, Rees AJ. Autoantibodies to glomerular antigens in patients with Wegener's granulomatosis. Nephrol Dial Transplant 1989; 4:1-8.
6. Ferraro G, Meroni PL, Tricani A, Sinco A, Barcellini W, Radice A. Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and microscopic polyarteritis. Clin Exp Immunol 1990; 79:47-53.
7. Savage COS, Pottinger BE, Gaskin G, Lookwood CM, Pusey CD, Pearson JD. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasmic antibodies. Clin Exp Immunol 1991; 85:14-19.
8. Baslund B, Wladimir S, Elzouki A-N, et al. Complexes between proteinase 3, α1-antitrypsin and proteinase 3 ANCA. A comparison between α1-antitrypsin PiZ allele-carriers and -noncarriers with Wegener's granulomatosis. Submitted.
9. Miller F, Kuschner M. Alpha-1-antitrypsin deficiency, emphysema, necrotizing angiitis and glomerulonephritis. Am J Med 1969; 46:615-23.
10. Lewis M, Kallenbach J, Zaltzman M, et al. Severe deficiency of alpha-1-antitrypsin associated with cutaneous vasculitis, rapidly progressive glomerulonephritis, and colitis. Am J Med 1985; 79:489-90.
11. Guerot E, Pechnick B, Guillevin L, et al. Vasculitis and severe alpha-1-antitrypsin deficiency. Eur J Intern Med 1989; 1:161-3.
12. Fortin PR, Fraser RS, Watts CS, Esdaile JM. Alpha-1-antitrypsin deficiency and systemic necrotizing vasculitis. J Rheumatol 1991; 18:1613-16.
13. Davis ID, Burke B, Freese D, Sharp HL, Kim Y. The pathologic spectrum of the nephropathy associated with alpha 1-antitrypsin deficiency. Hum Pathol 1992; 23:57-62.
14. Esnault VL, Testa A, Audrain M. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993; 43:1329-32.
15. Elzouki A-N, Segelmark M, Wieslander J, Eriksson S. Strong link between the alpha-1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med 1994; 236:543-8.
16. Segelmark M, Elzouki A-N, Wieslander J, Eriksson S. The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995; 48:844-50.
17. 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 1995; 100:194-7.
18. Griffith ME, Lovegrove JU, Gaskin G, Whitehouse DB, Pusey CD. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-I-antitrypsin, and p-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant 1996; 11:438-43.
19. 1-antitrypsin deficiency. Clin Exp Immunol 1995; 101(suppl. 1):42.
20. 1-AT) deficiency in Wegener's granulomatosis (WG). Clin Exp Immunol 1995; 101(suppl. 1):56.
21. Savige JA, Chang L, Daskalakis M, Doery J. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in ANCA-associated systemic vasculitis. Clin Exp Immunol 1995; 101(suppl. 1):56.
22. Mazodier P. Association entre dèficit en alpha-1-antitrypsine et maladie renale (revue de 48 cas dont 17 personnels). Le Pediatre 1977; XIII(60):205-19.
23. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101-7.
24. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Artheritis Rheum 1990; 33:1114-21.
25. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92.
26. Laurell CB. Electroimmunoassay. Scand J Clin Invest 1972; 124(suppl. 29):7-19.
27. 1-antitrypsin by electrofocusing. Clin Chemistry 1982; 28:219-22.
28. Watts RA, Carruthers DM, Scott DJ. Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1995; 25:28-34.
29. Stewart M, Savage JM, Bell B, et al. Long-term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr 1988; 147:113.
30. Michet CJ. Epidemiology of vasculitis. Rheum Dis Clin North Am 1990; 16:261-8.
31. Scott DGI, Bacon PA, Elliott PJ, et al. Systemic vasculitis in a district general hospital 1972-1980: Clinical and laboratory features, classification and prognosis of 80 cases. Q J Med 1982; 203:292.
32. 1-antitrypsin deficiency. Acta Medica Scand 1965; 432(suppl. 1):1-85.
33. 1-antitrypsin of Pi type M, S and Z. Eur J Biochem 1978; 53:143-53.
34. 1-antitrypsin phenotype MZ in acute anterior uveitis. Lancet 1978; i:1103.
35. Wakefield D, Breit SN, Clark P, Penny R. Immunogenetic factors in inflammatory eye disease. Influence of HLA-B27 and alpha-1-antitrypsin phenotype on disease expression. Arthritis Rheum 1982; 25:1431-4.
36. 1-Antitrypsin phenotype in fibrosing alveolitis and rheumatoid arthritis. Lancet 1977; ii:1049-50.
37. 1-antitrypsin deficiency and Weber-Christian disease. Arch Dermatol 1983; 119:198-202.
38. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85.
39. Anderson G, Coles ET, Crane M, et al. Wegener's granulomatosis. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British thoracic society research committee. Q J Med 1992; 83:427-38.
40. Serra A, Cameron JS, Turner DR, et al. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Med 1984; 53:181-207.
41. Sharp HL, Bridges RA, Krivit W, Freier EF. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 1969; 73:934-9.
42. Bergenfeldt M, Axelsson L, Ohlsson K. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest 1992; 52:823-9.
43. 1-proteinase inhibitor, J Clin Invest 1992; 89:766-73.
44. Breit SN, Wakefield D, Robinson JP, Luckhurst E, Clark P, Penny R. The role of α1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immun Immunopathol 1985; 35:363-80.
45. Soter NA, Austen KF. Pathogenetic mechanisms in the necrotizing vasculitides. Clin Rheumatic Dis 1980; 6(2):233-53.
46. Forsyth KD, Talbot V, Beckman I. Endothelial serpins protection of the vasculature? Clin Exp Immunol 1994; 95:277-82.
47. Anidjar S, Salzmann JL, Géntric D, Lagneau P, Camilleri JP, Michel JB. Elastase-induced experimental aneurysms in rats. Circulation 1990; 82:973-81.
48. Osborne-Pellegrin MJ, Farjanel J, Hornebeck W. Role of elastase and lysyl oxidase activity in spontaneous rupture of internal elastic lamina in rats. Arteriosclerosis 1990; 10:1136-46.
49. Ronco P, Verroust P, Mignon F, et al. Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies. Q J Med 1983; 206:212-23.
50. Busutill RW, Rinderbriecht H, Flesher A, Carmack C. Elastase activity: the role of elastase in aortic aneurysm formation. J Surg Res 1982; 32:214-17.
51. Cannon DJ, Read RC. Blood elastolytic activity in patients with aortic aneurysm. Am Thorac Surg 1982; 34:10-15.
52. Cohen JR, Mandell C, Chang JB, Wise L. Elastin metabolism of the infrarenal aorta. J Vasc Surg 1988; 7:210-14.
53. Cohen JR, Mandell C, Margolis I, Chang JB, Wise L. Altered aortic protease and antiprotease activity in patients with ruptured abdominal aortic aneurysms. Surg Gynecol Obstet 1987; 164:355-8.
54. Elzouki A-NY, Eriksson S. Abdominal aortic aneurysms and alpha 1-antitrypsin deficiency. J Intern Med 1994; 236:587-91.
55. 1-antitrypsin deficiency: etiologic implications. J Vasc Surg 1993; 17:420-4.
56. 1-Antitrypsin phenotypes in patients with abdominal aortic aneurysms. J Surg Res 1990; 49:319-21.
57. St Jean PL, Ferrell RE, Majumder PP, Steed DL, Webster MW. Abdominal aortic aneurysm (AAA): association with alpha 1-antitrypsin, haptoglobin and type III collagen. J Cardiovasc Surg 1991; 32(suppl. 1):38.
58. 1-antitrypsin deficiency, PiZ. Acta Med Scand 1978; 204:345-51.
59. 1-antitrypsin deficiency and intracranial aneurysms. Lancet 1994; 343:1037.
60. Hamilton MI, Dick R, Crawford L, Thompson NP, Pounder RE, Wakefield AJ. Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet 1995; 345:688-90.